NDC 61958-2005

DESCOVY

Emtricitabine And Tenofovir Alafenamide

DESCOVY is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is Emtricitabine; Tenofovir Alafenamide Fumarate.

• Product ID: 61958-2005_571559a0-e4c8-450f-9d29-0a1943330c6e
• NDC: 61958-2005
• Product Type: Human Prescription Drug
• Proprietary Name: DESCOVY
• Generic Name: Emtricitabine And Tenofovir Alafenamide
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2022-01-07
• Marketing Category: NDA /
• Application Number: NDA208215
• Labeler Name: Gilead Sciences, Inc.
• Substance Name: EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
• Active Ingredient Strength: 120 mg/1; mg/1
• Pharm Classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 61958-2005-1

30 TABLET in 1 BOTTLE, PLASTIC (61958-2005-1)

• Marketing Start Date: 2022-01-07
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "DESCOVY" or generic name "Emtricitabine And Tenofovir Alafenamide"

NDC	Brand Name	Generic Name
61958-2002	DESCOVY	emtricitabine and tenofovir alafenamide
61958-2005	DESCOVY	emtricitabine and tenofovir alafenamide
70518-0230	DESCOVY	emtricitabine and tenofovir alafenamide fumarate